THE QUITAK FOUNDATION
Advancement of education in accordance with the tenets and doctrines of the Jewish Faith; advancement of medical research; advancement of medical support services.
Financial health, per its FY2025 accounts
The accounts state that total unrestricted funds decreased to £3,027,657 from £3,271,678 in the prior year, primarily due to a net outgoing of resources and investment losses. The trustees maintain sufficient accessible funds to cover one year of administrative costs and committed grants, alongside a contingency fund. The charity does not actively fundraise and relies on investment income to support its grant-making activities.
What the accounts disclose
“The Trustees hold, in immediate accessible form, via short term money market holdings, sufficient funds to cover one year's administrative costs, the amount of grants already committed for the future twelve months, plus a contingency fund equal to the prior six months expenditure.” — page 6
“The professional fees were paid to Mr A Portnoy and the Investment Manager's fees were paid to JPM Asset Management Limited of which Mr J Meston is a director.” — page 13
Structured financials (annual return, FY ending 05/04/2022)
Trustees
- ALEX PORTNOY JP, FCCAchair
- GARY JOSEPH QUITAK
- JAMES ALEXANDER CHARLES MESTON
- MICHELLE HANNAH GINNO
- RUTH PORTNOY
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 05/04/2025 | £90k | £288k |
| 05/04/2024 | £71k | £210k |
| 05/04/2023 | £46k | £275k |
| 05/04/2022 | £2.0m | £100k |
| 05/04/2021 | £33k | £67k |
Common questions
Is THE QUITAK FOUNDATION financially healthy?
Per its FY2025 accounts: The accounts state that total unrestricted funds decreased to £3,027,657 from £3,271,678 in the prior year, primarily due to a net outgoing of resources and investment losses. The trustees maintain sufficient accessible funds to cover one year of administrative costs and committed grants, alongside a contingency fund. The charity does not actively fundraise and relies on investment income to support its grant-making activities. Its FY2025 accounts were independently examined.